意大利高级帕金森病治疗模式:一项观察性研究 中期分析
Fabrizio Stocchi1, Paolo Barone2, Roberto Ceravolo3
1Department of Neurology, University San Raffaele Roma and IRCCS San Raffaele, Rome, Italy.
Annals of medicine
|February 21, 2024
概括
管理帕金森病 (PD) 的波动是关键. 这项研究表明,优化利沃多巴和使用辅助药物可以稳定晚期PD,改善患者的生活质量.
科学领域:
- 神经学 神经学
- 运动障碍 运动障碍
- 药物治疗 药物治疗
背景情况:
- 口服乐伏多巴是帕金森病 (PD) 的首要治疗方法.
- 治疗反应的波动在晚期PD中很常见,这给管理带来了挑战.
- 关于管理PD波动的现实数据有限,特别是在晚期阶段.
研究的目的:
- 描述意大利高级PD患者的反应波动的现实生活管理.
- 在现实环境中分析患者人口统计,PD特征和治疗策略.
- 为了解决治疗反应波动的晚期PD的管理提供见解.
主要方法:
- 帕金森病波动治疗PAthway (PD-FPA) 研究是一项多中心的观察性研究.
- 分析了296名患有晚期PD和病史波动的患者的回顾性数据.
- 收集的数据包括患者病史,PD阶段,波动类型,症状和处方治疗.
主要成果:
- 大多数患者 (99.3%) 接受口服列沃多巴,并接受辅助疗法,包括多巴胺激动剂,MAO-B和COMT抑制剂.
- 响应波动是74%的患者治疗变化的主要原因.
- 磨损是最常见的波动类型,由83%的患者报告.
结论:
- 适当的利沃多巴剂量和适当的辅助药物可以有效地稳定晚期PD.
- 目前的管理策略似乎支持高级PD患者的良好生活质量.
- 该PD-FPA研究提供了关于管理PD波动的有价值的现实世界证据.
更多相关视频
相关概念视频
Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
Parkinson's Disease: Overview
546
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
546


